Omalizumab treatment and exercise capacity in severe asthmatics – Results from a pilot study
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine
Reference26 articles.
1. The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma;Buhl;Eur Respir J,2002
2. Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma;Buhl;Eur Respir J,2002
3. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma;Busse;J Allergy Clin Immunol,2001
4. Anti-immunoglobulin E (omalizumab) therapy in allergic asthma;Busse;Am J Respir Crit Care Med,2001
5. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics;Soler;Eur Respir J,2001
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of biologics on lung hyperinflation in patients with severe asthma;Respiratory Medicine;2024-04
2. Improvement of exertional dyspneoa in patients with chronic obstructive pulmonary disease and severe allergic asthma responding to omalizumab;Clinical & Experimental Allergy;2023-09-13
3. The impact of anti-eosinophilic therapy on exercise capacity and inspiratory muscle strength in patients with severe asthma;ERJ Open Research;2023-03
4. Does the severity of asthma affect exercise capacity and daily physical activity?;Journal of Asthma;2023-01-30
5. Static lung volumes and diffusion capacity in adults 30 years after being diagnosed with asthma;Asthma Research and Practice;2022-08-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3